1346175-04-9Relevant articles and documents
PYRROLO[2,3-B]PYRIDINE CDK9 KINASE INHIBITORS
-
, (2014/09/29)
Disclosed are compounds of Formula (IIa), wherein R1, R2, R3A, R3B, R3C, R3D, R3E, and R4 are as defined in the specification, and pharmaceutically acceptable salts thereof. The compounds may be used as agents in the treatment of diseases, including cancer. Also provided are pharmaceutical compositions comprising one or more compounds of Formula (IIa)
The application of Stille cross-coupling reactions with multiple nitrogen containing heterocycles
Selig, Roland,Schollmeyer, Dieter,Albrecht, Wolfgang,Laufer, Stefan
, p. 9204 - 9213 (2011/12/02)
Substituted imidazoles and purine bioisosteres have been widely studied in the literature. We endeavored to combine these heterocyclic core structures into precursors, especially 7-azaindoles, of previously unknown pharmacologically relevant lead structur